Thromboxane A2 induces contraction of human prostate smooth muscle by Rho kinase- and calmodulin-dependent mechanisms

European Journal of Pharmacology

Volumn 650, Issue 2-3, 2011, Pages 650-655

  Strittmatter, Frank ^a,b   Gratzke, Christian ^a   Weinhold, Philipp ^a   Steib, Christian J ^a   Hartmann, Anna C ^a   Schlenker, Boris ^a   Andersson, Karl Erik ^c   Hedlund, Petter ^b,d   Stief, Christian G ^a   Hennenberg, Martin ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Benign prostate hyperplasia; Lower urinary tract; Lower urinary tract symptoms; Smooth muscle; Thromboxane A2; U46619

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; CALCIUM ION; CALMODULIN; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; RHO KINASE; SYNTHETASE; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR; THROMBOXANE A2 SYNTHASE; UNCLASSIFIED DRUG; AMIDE; CALCIUM; ENZYME INHIBITOR; PYRIDINE DERIVATIVE; SULFONAMIDE; THROMBOXANE SYNTHASE; VASOCONSTRICTOR AGENT;

ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MALE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROSTATE; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE TONE; AGED; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; PHYSIOLOGY; SMOOTH MUSCLE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; AGED; AMIDES; CALCIUM; CALMODULIN; ENZYME INHIBITORS; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOHISTOCHEMISTRY; MALE; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PROSTATE; PYRIDINES; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RHO-ASSOCIATED KINASES; SULFONAMIDES; THROMBOXANE A2; THROMBOXANE-A SYNTHASE; VASOCONSTRICTOR AGENTS;

EID: 78651082265     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.10.052     Document Type: Article

References (30)

1. K.E. Andersson LUTS treatment: future treatment options Neurourol. Urodyn. 26 2007 934 947
2. K.E. Andersson, H. Lepor, and M.G. Wyllie Prostatic alpha 1-adrenoceptors and uroselectivity Prostate 30 1997 202 215
3. N. Chiang, and H.H. Tai The role of N-glycosylation of human thromboxane A2 receptor in ligand binding Arch. Biochem. Biophys. 352 1998 207 213
4. G.J. Christ, and K.E. Andersson Rho-kinase and effects of Rho-kinase inhibition on the lower urinary tract Neurourol. Urodyn. 26 2007 948 954
5. T. Dassesse, X. de Leval, L. de Leval, B. Pirotte, V. Castronovo, and D. Waltregny Activation of the thromboxane A2 pathway in human prostate cancer correlates with tumor Gleason score and pathologic stage Eur. Urol. 50 2006 1021 1031 discussion 1031
6. J.M. Dogne, X. de Leval, P. Benoit, J. Delarge, and B. Masereel Thromboxane A2 inhibition: therapeutic potential in bronchial asthma Am. J. Respir. Med. 1 2002 11 17 (Pubitemid 37038919)
7. J.M. Dogne, J. Hanson, X. de Leval, D. Pratico, C.R. Pace-Asciak, P. Drion, B. Pirotte, and K.H. Ruan From the design to the clinical application of thromboxane modulators Curr. Pharm. Des. 12 2006 903 923
8. C. Gratzke, T. Streng, E. Waldkirch, K. Sigl, C. Stief, K.E. Andersson, and P. Hedlund Transient receptor potential A1 (TRPA1) activity in the human urethra-evidence for a functional role for TRPA1 in the outflow region Eur. Urol. 55 2009 696 704
9. M. Hennenberg, J. Trebicka, T. Sauerbruch, and J. Heller Mechanisms of extrahepatic vasodilation in portal hypertension Gut 57 2008 1300 1314
10. M. Hennenberg, J. Trebicka, H.P. Fischer, J. Heller, and T. Sauerbruch Hepatic VASP upregulation in rats with secondary biliary cirrhosis by expression in the peribiliary vascular plexus Microvasc. Res. 78 2009 235 240
11. M. Hirata, Y. Hayashi, F. Ushikubi, Y. Yokota, R. Kageyama, S. Nakanishi, and S. Narumiya Cloning and expression of cDNA for a human thromboxane A2 receptor Nature 349 1991 617 620 (Pubitemid 21912117)
12. J.S. Huang, S.K. Ramamurthy, X. Lin, and G.C. Le Breton Cell signalling through thromboxane A2 receptors Cell. Signal. 16 2004 521 533
13. N. Liel, I. Nathan, T. Yermiyahu, Z. Zolotov, J.R. Lieberman, A. Dvilansky, and P.V. Halushka Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with pregnancy induced hypertension Thromb. Res. 70 1993 205 210
14. D.E. Mais, T.A. True, and M.J. Martinelli Characterization by photoaffinity labelling of the human platelet thromboxane A2/prostaglandin H2 receptor: evidence for N-linked glycosylation Eur. J. Pharmacol. 227 1992 267 274
15. C. Malmsten Some biological effects of prostaglandin endoperoxide analogs Life Sci. 18 1976 169 176
16. C. Martin, S. Uhlig, and V. Ullrich Cytokine-induced bronchoconstriction in precision-cut lung slices is dependent upon cyclooxygenase-2 and thromboxane receptor activation Am. J. Respir. Cell Mol. Biol. 24 2001 139 145
17. K. Matsuda, A. Ruff, T.A. Morinelli, R.S. Mathur, and P.V. Halushka Testosterone increases thromboxane A2 receptor density and responsiveness in rat aortas and platelets Am. J. Physiol. 267 1994 H887 893
18. M.C. Michel, and W. Vrydag Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate Br. J. Pharmacol. 147 Suppl 2 2006 S88 119
19. S.M. Miggin, and B.T. Kinsella Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) alpha and beta isoforms Biochim. Biophys. Acta 1425 1998 543 559
20. A. Miyata, C. Yokoyama, H. Ihara, S. Bandoh, O. Takeda, E. Takahashi, and T. Tanabe Characterization of the human gene (TBXAS1) encoding thromboxane synthase Eur. J. Biochem. 224 1994 273 279 (Pubitemid 24282809)
21. N. Nakahata Thromboxane A2: physiology/pathophysiology, cellular signal transduction and pharmacology Pharmacol. Ther. 118 2008 18 35
22. J.C. Nickel Inflammation and benign prostatic hyperplasia Urol. Clin. North Am. 35 2008 109 115 vii
23. D. Nie, Y. Guo, D. Yang, Y. Tang, Y. Chen, M.T. Wang, A. Zacharek, Y. Qiao, M. Che, and K.V. Honn Thromboxane A2 receptors in prostate carcinoma: expression and its role in regulating cell motility via small GTPase Rho Cancer Res. 68 2008 115 121
24. R. Nusing, G. Sauter, P. Fehr, U. Durmuller, M. Kasper, F. Gudat, and V. Ullrich Localization of thromboxane synthase in human tissues by monoclonal antibody Tu 300 Virchows Arch. A Pathol. Anat. Histopathol. 421 1992 249 254
25. D.A. Schwinn, and C.G. Roehrborn Alpha1-adrenoceptor subtypes and lower urinary tract symptoms Int. J. Urol. 15 2008 193 199
26. R.F. Shen, and H.H. Tai Thromboxanes: synthase and receptors J. Biomed. Sci. 5 1998 153 172
27. A.P. Somlyo, and A.V. Somlyo Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II J. Physiol. 522 Pt 2 2000 177 185
28. H.H. Tai, and B. Yuan Development of radioimmunoassay for thromboxane B2 Anal. Biochem. 87 1978 343 349
29. Y. Tone, A. Miyata, S. Hara, S. Yukawa, and T. Tanabe Abundant expression of thromboxane synthase in rat macrophages FEBS Lett. 340 1994 241 244
30. F. Ushikubi, M. Nakajima, M. Hirata, M. Okuma, M. Fujiwara, and S. Narumiya Purification of the thromboxane A2/prostaglandin H2 receptor from human blood platelets J. Biol. Chem. 264 1989 16496 16501